Emerging Treatments for Advanced, Unresectable Biliary Tract Cancer

IMPACT Medicom

English - October 07, 2022 14:00 - 14 minutes - 10.3 MB
Science impact medicom medical communications medical writing agency Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: Precision Medicine in Oncology Podcast Series: Ep12. Biomarkers for the treatment of breast cancer

Next Episode: ASH Highlights - ALPINE Trial Shows Improved Efficacy and Safety Profile of Zanubrutinib vs Ibrutinib in CLL

In this episode we discuss current and emerging systemic treatments for advanced, unresectable biliary tract cancers, as well as the barriers to accessing new treatments in Canada.

Our Guest:
Dr. Howard Lim is a Medical Oncologist, specializing in the treatment of gastrointestinal cancers at the BC Cancer Agency in Vancouver and Clinical Associate Professor in the Faculty of Medicine at the University of British Columbia.

This podcast episode was sponsored by AstraZeneca Canada.

If you enjoy our podcast, please review and subscribe. For more podcasts and other medical education content, visit our website at: https://www.impactmedicom.com